ALL	Acute lymphoblastic leukemia
AML	Acute myeloid leukemia
AP-1	Activator protein 1
B16	Name of murine melanoma cell line
BCL	B cell lymphoma
BCMA	B-cell maturation antigen
CAR-T	Chimeric antigen receptor T-cell
CARs	Chimeric antigen receptors
Cas9	CRISPR associated protein 9
CCL25	C-C motif chemokine ligand 25
CCR2	C-C motif chemokine receptor 2; cluster of differentiation 192
CCR9	C-C motif chemokine receptor 9
CD137 ζ	Cluster of differentiation 137 ζ
CD138	Syndecan-1; Cluster of differentiation 138
CD14	Cluster of differentiation 14
CD16	Cluster of differentiation 16
CD19	Cluster of differentiation 19
CD20	Cluster of differentiation 20
CD22	Cluster of differentiation 22
CD244	Cluster of differentiation 244
CD28	Cluster of differentiation 28
CD3	Cluster of differentiation 3
CD30	Tumor necrosis factor receptor superfamily member 8; Cluster of differentiation 30
CD33	Cluster of differentiation
CD3ζ	Cluster of differentiation 3ζ
CD4	Cluster of differentiation 4
CD8	Cluster of differentiation 8
CLL	Chronic lymphocytic leukemia
CML	Chronic myelogenous leukemia
CR	Complete response
CRISPR	Clustered regularly interspaced palindromic repeats
CRS	Cytokine release syndrome
DCs	Dendritic cells
DLBCL	Diffuse large B-cell lymphoma
EG7	Name of cell line derived from murine T-cell lymphoma
EGFRt	Epidermal growth factor receptor
EPCs	Endothelial progenitor cells
FcRγ	Fc receptor gamma
FDA	Food and Drug Administration
GvHD	Graft versus host disease
GvT	Graft versus tumor effect
HLA	Human leukocyte antigen
HSCs	Hematopoietic stem cells
IFN-γ	Human interferon gamma
IL-2	Interleukin 2
iPS-MEF-Ng-20D-17	Name of mouse induced pluripotent stem cell line
iPSCs	Induced pluripotent stem cells
K562	Human erytroleukemic cell line
Klf4	Kruppel-like factor 4
L1210	Name of murine cancer cell line derived from lymphoblasts
LeY	Lewis Y antigen
M1	Macrophage phenotype 1
M2	Macrophage phenotype 2
MDS	Myelodysplastic syndrome
Megf10	Multiple epidermal growth factor-like domains 10
MHC	Major histocompatibility complex
MM	Multiple myeloma
MRD	Minimal residual disease
mRNA	Messenger ribonucleic acid
MSCs	Mesenchymal stem cells
Myc	Master regulator of cell cycle entry and proliferative metabolism
Nalm6	Human B cell precursor leukemia cell line
NF-κB	Nuclear factor kappa-light-chain-enhancer of activated B cells
NFAT	Nuclear factor of activated T-cells
NHL	Non-Hodgkin’s lymphoma
NK	Natural killer
NK-92	Name of human NK cell line
NK1.1	NK cell-associated marker 1.1; cluster of differentiation 161
NKG2D	Natural killer group 2D receptor
NKp46	Natural cytotoxicity triggering receptor 1; cluster of differentiation 335
NKT	Natural killer T cells
NT	Neurotoxicity
NY-ESO-1	Cancer-testis antigen
Oct3/4	Octamer-binding transcription factor 4
OP9	Name of murine embryonic cell line
OR	Objective response
PD	Progressive disease
PDGF-BB	Platelet-derived growth factor BB
PR	Partial response
RD114	Name of envelope glycoprotein of lentiviral vectors
RPMI8226	Name of multiple myeloma human cancer cell line derived from B lymphocytes
scFv	Single-chain variable fragment
SCR	Sustained complete response
SCs	Stem cells
SD	Stable disease
SDF-1	Stromal cell derived factor 1
Sox2	Sex determining region Y-box 2
sTRAIL	Soluble TNF-related apoptosis-inducing ligand
SUPRA	Split Universal Programmable
TAAs	Tumor-associated antigens
TCR	T cell receptor
TGF-β	Transforming growth factor β
TNF-α	Tumor necrosis factor alpha
TRAIL	Tumor necrosis factor-related apoptosis-inducing ligand
TRUCKs	T cells redirected for universal cytokine-mediated killing
U-266	Name of human cancer cell line derived from B lymphocyte
VEGF	Vascular endothelial growth factor
VGPR	Very good partial remission
VSV-G	Vesicular stomatitis virus G
WT1	Wilms’ tumor 1
4T1	Murine mammary tumor cell line